Support Groups

Johnson & Johnson reinventing party drug Ketamine to treat depression.

Johnson & Johnson Ketamine Depression

Until joining the company a few years ago, J&J neuroscience R&D head Husseini Manji led the mood and anxiety disorders program at the National Institutes of Health. While there, he helped run a program that led to one of the greatest breakthroughs in psychiatry in recent years: the knowledge that a brain receptor called the … Read more

Researchers at University of Maryland School Of Medicine could revolutionize Depression treatment.

depression

Recent discovery by a team of researchers at the University of Maryland School Of Medicine could revolutionize how we deal with depression. Extra special K. Depression is a difficult problem to solve. We don’t fully understand what causes it and therefore we have difficulty developing treatments for it. Luckily, new research may have found a … Read more

That Vitamin Movie

That Vitamin Movie

Fast forward to 10:00 and listen until 10:40…. over and over until you hear it!
Click to watch the video for a free screening/

Drugs and surgery are not the only answer.

  • Medical schools get a lot of $ from drug companies.
  • The Media get a lot of advertising revenue $ from drug companies.
  • Researchers get a lot of research grant $ from drug companies.
  • The government is lobbied heavily $ by drug companies.

Its not by accident, its carefully “planned design” by Big Pharma.

Can we admit were Brainwashed? See more.

NIH researchers discover Ketamine can lift depression in hours or even minutes

Ketamine

In a series of studies carried out by NIH, scientists at the University of Maryland School of Medicine, working together with the National Institutes of Mental Health, researchers discovered how Ketamine can lift Depression in a matter of hours or even minutes — when administered in a controlled setting, adding that the effects of a … Read more

Experimental Medication Lifts Depression Symptoms in Bipolar Disorder Within an Hour

Nih Logo

People with treatment-resistant bipolar disorder experienced relief from symptoms of depression in as little as 40 minutes after an intravenous dose of the anesthetic medication ketamine in a preliminary study; while the patient group was small, this work adds to evidence that compounds in the class to which ketamine belongs have potential as rapid and … Read more

Ketamine Lifts Depression via a Byproduct of its Metabolism

Nih Logo

NIH-funded team finds rapid-acting, non-addicting agent in mouse study. A chemical byproduct, or metabolite, created as the body breaks down ketamine likely holds the secret to its rapid antidepressant action, National Institutes of Health (NIH) scientists and grantees have discovered. This metabolite singularly reversed depression-like behaviors in mice without triggering any of the anesthetic, dissociative, … Read more

Light Exposure Study

U of A Dept of Psychiatry Studies

Study Overview: We are conducting a study at the University of Arizona to understand the effectiveness of a six-week course of light exposure on cognitive functioning, mood, activity, and sleep in people that have suffered a head injury leading to a mild traumatic brain injury or “concussion.” Participants will undergo a series of surveys and … Read more

Being Mad about Psychiatry & Psychiatric Medications

angry, anger

I used to be a person who was very mad about psychiatry and psychiatric medication (psych meds). I had that vehement anger we often hear from antipsychiatrists although I was not antipsychatiry, per se. My biggest fantasy, at the time, was to take the horrible medications I was prescribed and shove them down the throat … Read more

Treating Depression With Non-Invasive Vagus Nerve Stimulation

Transcutaneous VNS

Depression can be a devastating and unremitting problem. Researchers of a new study published in the current issue of Biological Psychiatry report successful reduction of depressive symptoms in patients using a novel non-invasive method of vagus nerve stimulation, or VNS. Despite the growing number of medications and neurostimulation approaches available, residual symptoms may be both … Read more